Rivoglitazone: a new thiazolidinedione for the treatment of type 2 diabetes mellitus.
about
Chemotherapy and chemoprevention by thiazolidinedionesClassification of Therapeutic and Experimental Drugs for Brown Adipose Tissue Activation: Potential Treatment Strategies for Diabetes and ObesityIntegrative Genomic Analyses Yield Cell-Cycle Regulatory Programs with Prognostic ValueThiazolidinedione drugs in the treatment of type 2 diabetes mellitus: past, present and future.Overview of clinically approved oral antidiabetic agents for the treatment of type 2 diabetes mellitus.
P2860
Rivoglitazone: a new thiazolidinedione for the treatment of type 2 diabetes mellitus.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Rivoglitazone: a new thiazolidinedione for the treatment of type 2 diabetes mellitus.
@en
type
label
Rivoglitazone: a new thiazolidinedione for the treatment of type 2 diabetes mellitus.
@en
prefLabel
Rivoglitazone: a new thiazolidinedione for the treatment of type 2 diabetes mellitus.
@en
P2093
P2860
P356
P1476
Rivoglitazone: a new thiazolidinedione for the treatment of type 2 diabetes mellitus.
@en
P2093
Haley M Phillippe
Kurt A Wargo
Robin L Koffarnus
P2860
P304
P356
10.1345/APH.1R754
P407
P577
2013-04-30T00:00:00Z